Validación de biomarcadores plasmáticos para la detección temprana y específica de la enfermedad de Alzheimer y evaluación pronóstica a 2 años.
Datos básicos
- Código:
- CNS2022-135327
- Protocolo:
- CNS2022-135327
- EUDRACT:
- NCT:
- Centro:
- Dotación:
- 182.895,00 €
- Año de incio:
- 2023
- Año de finalización:
- 2025
Documentos
- No hay documentos
Participantes
Financiadores - Promotores
Resultados del Ensayo Clínico
Assessment of COVID-19 lockdown effect on early Alzheimer Disease progression.
Pena-Bautista, Carmen; (...); Chafer-Pericas, Consuelo
Article. 10.1007/s00415-023-11899-5. 2023
Associations between antidiabetic medications and cerebrospinal fluid biomarkers of Alzheimer's disease.
Garcia-Lluch, Gemma; (...); Chafer-Pericas, Consuelo
Article. 10.1177/13872877241304995. 2024
Author Correction: Brain areas lipidomics in female transgenic mouse model of Alzheimer's disease.
Ferré-González L; (...); Cháfer-Pericás C
Correction. 10.1038/s41598-024-52528-z. 2024
Brain areas lipidomics in female transgenic mouse model of Alzheimer's disease
Ferre-Gonzalez, Laura; (...); Chafer-Pericas, Consuelo
Article. 10.1038/s41598-024-51463-3. 2024
Cardiovascular Risk Scales Association with Cerebrospinal Fluid Alzheimer's Disease Biomarkers in Cardiovascular Low Cardiovascular Risk Regions.
García-Lluch G; (...); Cháfer-Pericás C
Article. 10.14283/jpad.2024.16. 2024
Defining Alzheimer's Disease through Proteomic CSF Profiling.
Pena-Bautista, Carmen; (...); Chafer-Pericas, Consuelo
Article. 10.1021/acs.jproteome.4c00590. 2024
Early Alzheimer's Disease Screening Approach Using Plasma Biomarkers
Alvarez-Sanchez, Lourdes; (...); Chafer-Pericas, Consuelo
Article. 10.3390/ijms241814151. 2023
Fast Declining Prediction in Alzheimer's Disease from Early Clinical Assessment.
Álvarez-Sánchez L; (...); Pericás CC
Article. 10.2174/011570159X332930240925095423. 2024
Influence of Statin Potency and Liposolubility on Alzheimer's disease patients: a population-based study.
Garcia-Zamora, Mar; (...); Chafer-Pericas, Consuelo
Article. 10.1016/j.phrs.2024.107446. 2024
Insights from a 7-Year Dementia Cohort (VALCODIS): ApoE Genotype Evaluation.
Baquero, Miguel; (...); Chafer-Pericas, Consuelo
Article. 10.3390/jcm13164735. 2024
New approach for early and specific Alzheimer disease diagnosis from different plasma biomarkers.
Forte, Anabel; (...); Chafer-Pericas, Consuelo
Article. 10.1016/j.cca.2024.117842. 2024
Plasma lipidomics in early APP/PS1 female mouse model and its relationship with brain: Is it affected by the estrous cycle?
Ferre-Gonzalez, Laura; (...); Chafer-Pericas, Consuelo
Article. 10.1186/s13195-024-01549-x. 2024
Relationship between neuroimaging and emotion recognition in Mild Cognitive Impairment patients.
Gandia-Ferrero, Maria Teresa; (...); Marti-Bonmati, Luis
Article. 10.1016/j.bbr.2023.114844. 2024
Relationship between Plasma Lipid Profile and Cognitive Status in Early Alzheimer Disease.
Pena-Bautista, Carmen; (...); Chafer-Pericas, Consuelo
Article. 10.3390/ijms25105317. 2024
Response to letter to the editor: An in-depth look at the relationship between anti-diabetic drugs and Alzheimer's disease.
Garcia-Zamora, Mar; (...); Pardo Albiach, Juan
Letter. 10.1016/j.phrs.2024.107396. 2024
Response to letter to the editor: Expanding perspectives on the relationship between statin potency and lipophilicity in Alzheimer's disease management.
Garcia-Zamora, Mar; (...); Pardo, Juan
Letter. 10.1016/j.phrs.2025.107595. 2025